25 Oct 2022
Ahpra- 25th October 2022
A Victorian podiatrist has been suspended for four months for professional misconduct, after failing to hold professional indemnity insurance (PII), making false declarations and providing false and/or misleading information.
25 Oct 2022
Ahpra - 25th October 2022
A former registered Victorian dentist has been reprimanded and disqualified from applying for registration until April 2023 for professional misconduct.
24 Oct 2022
The Department of Healthcare and Aged Care - 24th October 2022
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.
24 Oct 2022
The Department of Healthcare and Aged Care- 24th October 2022
The Australian Government will invest $16.9 million to support the transition of 15 cutting-edge projects into clinical practice. Funding is from the Medical Research Future Fund (MRFF).
24 Oct 2022
The Department of Healthcare and Aged Care_ 24th October 2022
Medical Research Future Fund (MRFF) grant opportunities to the value of $86 million are now available.
24 Oct 2022
The Department of Healthcare and Aged care- 24th October 2022
Cancer Australia’s Yarn for Life is the first national cancer awareness campaign developed for and by Aboriginal and Torres Strait Islander people.
21 Oct 2022
PBS Website- 21st October 2022
Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 (Amendment Act) give effect to the commitments in the new Strategic Agreements with the medicines industry (2022-2027)
20 Oct 2022
The Royal Australian College of General Practitioners (RACGP) - 20 October 2022
The Royal Australian College of General Practitioners (RACGP) has welcomed the Pharmaceutical Benefits Advisory Committee (PBAC) recommending adding COVID-19 oral antivirals to the Prescriber Bag or “doctor’s bag”.
20 Oct 2022
PBS Website- 20th October 2022
The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised draft of the Pharmaceutical Benefits Scheme (PBS) Post-market Review (PMR) Framework.